NKP-1339 is the first-in-class ruthenium-based anticancer drug in clinical development against solid cancer and has recently been studied successfully in a phase I clinical trial.
Molekulargewicht:
502.14
CAS Nummer:
[197723-00-5]
Formel:
C14H12Cl4N4NaRu
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten